Septerna (SEPN) Net Margin (2023 - 2026)

Septerna (SEPN) recorded quarterly Net Margin of 32.59% in Q1 2026, up 26.8% quarter-over-quarter from 44.52% in Q4 2025, and up 977380.0% on a YoY basis from N/an in Q1 2025.

Septerna (SEPN) Net Margin (2023 - 2026) Analysis & Trends

Septerna's Net Margin history runs 4 years deep, the most recent figure standing at 32.59% for Q1 2026.

  • In Q1 2026, Net Margin rose 977380.0% year-over-year to 32.59%; the TTM figure through Mar 2026 stood at 49.89% (up 806945.0% YoY), while the FY2025 annual figure was 106.37%, up 657251.0% from the prior year.
  • Net Margin was 32.59% for Q1 2026 at Septerna, up from 44.52% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 38.02% in Q3 2025 to a low of 33166.67% in Q3 2023.
  • Historically, Net Margin has averaged 9973.46% across 4 years, with a median of 9749.06% in 2024.
  • The sharpest annual moves came in 2024 and 2025: Net Margin soared 2150587 bps in 2024, then sank 1636984 bps in 2025.
  • A 4-year view of Net Margin shows it stood at 15383.9% in 2023, then jumped by 37 bps to 9749.06% in 2024, then surged by 100 bps to 44.52% in 2025, then increased by 27 bps to 32.59% in 2026.
  • The last three Net Margin figures came in at 32.59% (Q1 2026), 44.52% (Q4 2025), and 38.02% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Septerna 1.62 Bn 1.62 Bn - -32.59%

Historic Data

Download Data
DateValue
Mar 31, 2026 -32.59%
Dec 31, 2025 -44.52%
Sep 30, 2025 38.02%
Jun 30, 2025 -20,872.27%
Mar 31, 2025 -9,806.39%
Dec 31, 2024 -9,749.06%
Sep 30, 2024 -11,660.80%
Jun 30, 2024 -4,502.43%
Mar 31, 2024 -4,527.44%
Dec 31, 2023 -15,383.90%
Sep 30, 2023 -33,166.67%